Does Restriction of the Dominant Hand Due to Injury Improve Non-Dominant Hand Function?
Launched by GAZI UNIVERSITY · Jan 14, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether keeping your dominant hand in a splint after an injury can help improve the function of your non-dominant hand. When people injure their dominant hand, they often have to use their non-dominant hand more in daily activities. This study aims to see if this increased use leads to better function in the non-dominant hand during the crucial healing period of six weeks.
To participate, you should be between 18 and 65 years old and need to wear a splint on your dominant hand within 10 days after an operation. However, you cannot have an isolated thumb injury, need a splint on both hands, or be unable to use your non-dominant hand. If you join the study, you'll be monitored during the six weeks you wear the splint to see how your non-dominant hand performs. This research could help us understand how hand injuries affect daily life and possibly improve recovery strategies for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals who need to use a splint for 6 weeks due to any pathology in their dominant hand
- • Ages between 18-65
- • Individuals who are within the first 10 days after the operation
- Exclusion Criteria:
- • Individuals with an isolated thumb injury
- • Those who require bilateral use of the splint/have bilateral pathology
- • Those who have a condition that prevents the use of the non-dominant hand
- • Those who can use both hands equally/do not have a dominant side (ambidextrous/two-handed)
- • Those who have a cooperative status that will not comply with the treatment program
- • Data from individuals who do not use the splint as described during the 6-week follow-up period will not be included in the analysis.
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Yenimahalle, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported